Vivos (RDGL) Operating Leases (2025)
Vivos (RDGL) posted Operating Leases of $88851.0 for Q4 2025.
Vivos (RDGL) Operating Leases (2025) Analysis & Trends
Vivos has reported Operating Leases for 1 years, with the latest figure at $88851.0 in Q4 2025.
- Quarterly Operating Leases changed N/A year-over-year to $88851.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $88851.0 (changed N/A YoY) and the FY2025 annual result came in at $88851.0, changed N/A from the prior year.
- Operating Leases held at $88851.0 in Q4 2025 per RDGL's latest filing.
- Over five years, Operating Leases peaked at $88851.0 in Q4 2025 and troughed at $88851.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn |
| 10 | Vivos | 24.90 Mn | 23.34 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 88,851.00 |